Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung

Lung Cancer

Volumn 50, Issue 2, 2005, Pages 177-188

  Péqueux, Christel ^a   Breton, Christophe ^b   Hagelstein, Marie Thérèse ^a   Geenen, Vincent ^a   Legros, Jean Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIV LILLE   (France)

Author keywords

Endothelium; Lung; Non small cell lung carcinoma; Oxytocin receptor; Small cell lung carcinoma; Vasopressin receptors

Indexed keywords

HORMONE ANTAGONIST; HORMONE RECEPTOR; MESSENGER RNA; NEUROHYPOPHYSIS HORMONE; OXYTOCIN RECEPTOR; RECEPTOR SUBTYPE; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; LUNG CANCER; LUNG ENDOTHELIUM; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MALE; MITOGENESIS; NEUROHYPOPHYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR BIOPSY; VASCULAR ENDOTHELIUM;

AGED; AUTOPSY; BIOPSY; CARCINOMA, SMALL CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 26444554550     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.05.027     Document Type: Article

References (47)

1. K.-M. Müller Lung cancer: morphology. S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer 2001 European respiratory Society UK 34 47
2. G.K. Dy, and A.A. Adjei Novel targets for lung cancer therapy: part I J Clin Oncol 20 2002 2881 2894
3. D.V. Johnson, and C.D. Blanke Small cell lung cancer: diagnosis, treatment and natural history A.P. Fishman A.P. Fishman Fishman's pulmonary diseases and disorders 1998 McGraw-Hill Health Professions Division NY 1819 1831 [chapter 114]
4. H. Skuladottir, and J.H. Olsen Epidemiology of lung cancer S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer. 2001 European respiratory Society UK 1 12
5. A.C. Kraus, I. Ferber, S.O. Bachmann, H. Specht, A. Wimmel, and M.W. Gross In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways Oncogene 21 2002 8683 8695
6. U. Gatzemeier, and M. Reck New chemotherapeutic agents S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer. 2001 European respiratory Society UK 259 269
7. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392
8. W.G. North Gene regulation of vasopressin and vasopressin receptors in cancer [Review] [101 refs] Exp Physiol 85 2000 27S 40S
9. E. Rozengurt Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer Curr Opin Oncol 11 1999 116 122
10. E. Rozengurt Neuropeptides as growth factors for normal and cancerous cells Trends Endocrinol Metab 13 2002 128 134
11. L.E. Heasley Autocrine and paracrine signaling through neuropeptide receptors in human cancer Oncogene 20 2001 1563 1569
12. W.B. Schwartz, W. Bennet, S. Curelop, and F.C. Bartter A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone Am J Med 23 1957 529
13. T.T. Amatruda, P.J. Mulrow, J.C. Gallagher, and W.H. Sawyer Carcinoma of the lung with inappropriate antidiuresis. Demonstration of an antidiuretic-hormone-like activity in tumor extract N Engl J Med 269 1963 544
14. B.F. Bower, D.M. Mason, and P.H. Forsham Bronchogenic carcinoma with inappropriate antidiuretic activity in plasma and tumor N Engl J Med 271 1964 934
15. F.C. Bartter, and W.B. Schwartz The syndrome of inappropriate secretion of antidiuretic hormone [Review] [154 refs] Am J Med 42 1967 790 806
16. W.G. North, M.J. Fay, K.A. Longo, and J. Du Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide Cancer Res 58 1998 1866 1871
17. C. Péqueux, C. Breton, J.-C. Hendrick, M-T. Hagelstein, H. Martens, and R. Winkler Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through an autocrine/paracrine signaling Cancer Res 62 2002 4623 4629
18. J.J. Legros, V. Geenen, T. Carvelli, H. Martens, M. Andre, and J.L. Corhay Neurophysins as markers of vasopressin and oxytocin release. A study in carcinoma of the lung Hormone Res 34 1990 151 155
19. W.G. North, A.S. Friedmann, and X. Yu Tumor biosynthesis of vasopressin and oxytocin [Review] [47 refs] Ann N Y Acad Sci 689 1993 107 121
20. C. Péqueux, J.-C. Hendrick, M.-T. Hagelstein, V. Geenen, and J.-J. Legros Novel plasma extraction procedure and development of a specific enzyme-immunoassay of oxytocin: application to clinical and biological investigations of small cell carcinoma of the lung Scand J Clin Lab Invest 61 2001 407 416
21. P. Cassoni, T. Marrocco, S. Deaglio, A. Sapino, and G. Bussolati Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors Ann Oncol 12 2001 S37 S39
22. G. Bussolati, and P. Cassoni Editorial: the oxytocin/oxytocin receptor system-expect the unexpected Endocrinology 142 2001 1377 1379
23. C. Péqueux, B.P. Keegan, M.-T. Hagelstein, V. Geenen, J.-J. Legros, and W.G. North Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway Endocr Relat Cancer 11 2004 871 885
24. A. Hirasawa, K. Hashimoto, and G. Tsujimoto Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats Eur J Pharmacol 267 1994 71 75
25. A. Tahara, Y. Tomura, K. Wada, T. Kusayama, J. Tsukada, and N. Ishii Characterization of vasopressin receptor in rat lung Neuropeptides 32 1998 281 286
26. S.J. Lolait, A.M. O'Carroll, L.C. Mahan, C.C. Felder, D.C. Button, and W.S. Young 3rd Extrapituitary expression of the rat V1b vasopressin receptor gene Proc Natl Acad Sci USA 92 1995 6783 6787
27. M.J. Fay, J. Du, X. Yu, and W.G. North Evidence for expression of vasopressin V2 receptor mRNA in human lung Peptides 17 1996 477 481
28. J.E. Kaufmann, A. Oksche, C.B. Wollheim, G. Gunther, W. Rosenthal, and U.M. Vischer Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP J Clin Invest 106 2000 107 116
29. G. Gimpl, and F. Fahrenholz The oxytocin receptor system: structure, function, and regulation Physiol Rev 81 2001 629 683
30. H.H. Zingg, and S.A. Laporte The oxytocin receptor Trends Endocrinol Metab 14 2003 222 227
31. G. Bussolati, P. Cassoni, G. Ghisolfi, F. Negro, and A. Sapino Immunolocalization and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast Am J Pathol 148 1996 1895 1903
32. T. Kimura, O. Tanizawa, K. Mori, M.J. Brownstein, and H. Okayama Structure and expression of a human oxytocin receptor [published erratum appears in Nature 1992 May 14;357(6374):176] Nature 356 1992 526 529
33. M. Thibonnier, C. Auzan, Z. Madhun, P. Wilkins, L. Berti-Mattera, and E. Clauser Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor J Biol Chem 269 1994 3304 3310
34. T. Sugimoto, M. Saito, S. Mochizuki, Y. Watanabe, S. Hashimoto, and H. Kawashima Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor J Biol Chem 269 1994 27088 27092
35. M. Birnbaumer, A. Seibold, S. Gilbert, M. Ishido, C. Barberis, and A. Antaramian Molecular cloning of the receptor for human antidiuretic hormone Nature 357 1992 333 335
36. G.A. Blobel, V.E. Gould, R. Moll, I. Lee, M. Huszar, and B. Geiger Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms Lab Invest 52 1985 39 51
37. K. Kayser, W. Schmid, W. Ebert, and B. Wiedenmann Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung Pathol Res Pract 183 1988 412 417
38. W. Ebert, T. Muley, and P. Drings Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 16 1996 2161 2168
39. T. Muley, W. Ebert, P. Stieber, H. Raith, S. Holdenrieder, and D. Nagel Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay Clin Chem Lab Med 41 2003 95 103
40. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31 1982 11 24
41. M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, and S.C. Erzurum Human vascular endothelial cells express oxytocin receptors Endocrinology 140 1999 1301 1309
42. M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S.M. McCann, and J. Gutkowska Oxytocin and its receptors are synthesized in the rat vasculature Proc Natl Acad Sci USA 97 2000 6207 6211
43. T. Sethi, and E. Rozengurt Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin Cancer Res 51 1991 3621 3623
44. A.P. Meert, B. Martin, J.M. Verdebout, M. Paesmans, T. Berghmans, and V. Ninane Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer Lung Cancer 44 2004 295 301
45. W.G. North, M.J. Fay, and J. Du All three vasopressin receptor sub-types are expressed by small-cell carcinoma Adv Exp Med Biol 449 1998 335 338
46. W.G. North, M.J. Fay, and J. Du MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R Peptides 20 1999 837 842
47. D. Firsov, B. Mandon, A. Morel, J. Merot, S. Le Maout, and A.C. Bellanger Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor Pflugers Arch 429 1994 79 89